Processing of amyloid precursor protein in human primary neuron and astrocyte cultures

Journal of Neurochemistry

Volumn 68, Issue 3, 1997, Pages 1183-1190

  LeBlanc, Andréa C ^a,b   Papadopoulos, Maria ^a,b   Bélair, Caroline ^a,b   Chu, William ^a,b   Crosato, Milena ^b   Powell, Jaqueline ^b   Goodyer, Cynthia G ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Alzheimer's disease; Amyloid precursor protein; Amyloid peptide; Human astrocytes; Human microglia; Human primary neuron cultures

Indexed keywords

AMYLOID PRECURSOR PROTEIN; MESSENGER RNA;

ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; CARBOXY TERMINAL SEQUENCE; CELL LABELING; FETUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; MICROGLIA; NERVE CELL CULTURE; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN SECRETION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

GILA;

EID: 0031017752     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.68031183.x     Document Type: Article

References (53)

1. Burdick D., Soreghan B., Kwon M., Kosmoski J., Knauer M., Menschen A., Yates J., Cotman C., and Glabe C. (1992) Assembly and aggregation properties of synthetic Alzheimer's A4/β amyloid peptide analogs. J. Biol. Chem. 267, 546-554.
2. Busciglio J., Gabuzda D., Matsudaira P., and Yankner B. (1993) Generation of β-amyloid in the secretory pathway in neuronal and nonneuronal cells. Proc. Natl. Acad. Sci. USA 90, 2092-2096.
3. Cai X., Golde T., and Younkin S. (1993) Release of excess amyloid β protein from a mutant amyloid β protein precursor. Science 259, 514-516.
4. Cheung T., Ghiso J., Shoji M., Cai X., Golde T., Gandy S., Frangione B., and Younkin S. (1994) Characterization by radiosequencing of the carboxyl-terminal derivatives produced from normal and mutant amyloid β protein precursors. Amyloid Int. J. Exp. Clin. Invest. 1, 30-38.
5. Chomczynski P. and Sacchi N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
6. Citron M., Oltersdorf T., Haass C., McConlogue L., Hung A., Seubert P., Vigo-Pelfrey C., Lieberburg I., and Selkoe D. (1992) Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-amyloid protein production. Nature 360, 672-679.
7. Citron M., Vigo-Pelfrey C., Teplow D., Miller C., Schenk D., Johnston J., Winblad B., Venizelos N., Lannfelt L., and Selkoe D. (1994) Excessive production of amyloid β-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation. Proc. Natl. Acad. Sci. USA 91, 11993-11997.
8. De Strooper B., Craessaerts K., Dewachter I., Moechars D. G. B., Van Leuvan F., and Van Den Berghe H. (1995) Basolateral secretion of amyloid precursor protein in Mardin-Darby canine kidney cells is disturbed by alterations of intracellular pH and by introducing a mutation associated with familial Alzheimer's disease. J. Biol. Chem. 270, 4058-4065.
9. Estus S., Golde T., Kunishita T., Blades D., Lowery D., Eisen M., Usiak M., Qu X., Tabira T., Greenberg B., and Younkin S. (1992) Potentially amyloidogenic, carboxy-terminal derivatives of the amyloid protein precursor. Science 255, 726-728.
10. Games D., Adams D., Alessandrini R., Barbour R., Berthelette P., Blackwell C., Carr T., Clemens J., Donaldson T., Gillespie F., Guido T., Hagopian S., Johnson-Wood K., Khan K., Lee M., Leibowitz P., Lieberburg I., Little S., Masliah E., McConlogue L., Montoya-Zavala M., Mucke L., Paganini L., Penniman E., Power M., Schenk D., Seubert P., Snyder B., Soriano F., Tan H., Vitale J., Wadsworth S., Wolozin B., and Zhao J. (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid protein. Nature 373, 523-527.
11. Golde T., Estus S., Younkin L., Selkoe D., and Younkin S. (1992) Processing of the amyloid protein precursor to potentially amyloidogenic derivatives. Science 255, 728-730.
12. Haass C., Koo E., Mellon A., Hung A., and Selkoe D. (1992a) Targeting of cell-surface β-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments. Nature 357, 500-503.
13. Haass C., Schlossmacher M., Hung A., Vigo-Pelfrey C., Mellon A., Ostaszewski B., Lieberburg I., Koo E., Schenk D., Teplow D., and Selkoe D. (1992b) Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature 359, 322-325.
14. Haass C., Hung A., Schlossmacher M., Teplow D., and Selkoe D. (1993) β-Amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms. J. Biol. Chem. 268, 3021-3024.
15. Haass C., Hung A., Selkoe D., and Teplow D. (1994) Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid β-protein precursor. J. Biol. Chem. 269, 17741-17748.
16. Haass C., Koo E. H., Capell A., Teplow D., and Selkoe D. (1995a) Polarized sorting of β-amyloid precursor protein and its proteolytic products in MDCK cells is regulated by two independent signals. J. Cell Biol. 128, 537-547.
17. Haass C., Lemere C., Capell A., Citron M., Seubert P., Schenk D., Lannfelt D., and Selkoe D. (1995b) The Swedish mutation causes early-onset Alzheimer's disease by β-secretase cleavage within the secretory pathway. Nature Med. 1, 1291-1296.
18. Higgins L. S., Rodems J. M., Catalano R., and Cordell B. (1995) Early Alzheimer disease-like histopathology increases in frequency with age in mice transgenic for β-APP751. Proc. Natl. Acad. Sci. USA 92, 4402-4406.
19. Hsiao K., Borcheldt D., Olson K., Johannsdottir R., Kitt C., Yunis W., Xu S., Eckman C., Younkin S., Price D., Iadecola C., Clark B., and Carlson G. (1995) Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor protein. Neuron 15, 1203-1208.
20. Huber L. A., de Hoop M. J., Dupree P., Zerial M., Simons K., and Dotti C. (1993) Protein transport to the dendritic plasma membrane of cultured neurons is regulated by rab8p. J. Cell Biol. 123, 47-55.
21. Kim K., Miller D., Sapienza V., Chen C., Bai C., Grundke-Iqbal I., Currie J., and Wisniewski H. (1990a) Production and characterization of monoclonal antibodies reactive to synthetic cerebrovascular amyloid peptide. Neurosci. Res. Commun. 2, 121-130.
22. Kim K. S., Wen G. Y., Bancher C., Chen C. M. J., Sapienza V. J., Hong H., and Wisniewski H. M. (1990b) Detection and quantitation of amyloid β-peptide with 2 monoclonal antibodies. Neurosci. Res. Commun. 7, 113-122.
23. Koo E. H. and Squazzo S. L. (1994) Evidence that production of amyloid β-protein involves the endocytotic pathway. J. Biol. Chem. 269, 17386-17389.
24. Kuentzel C., Caporaso G., Thyberg J., Gandy S., and Greengard P. (1993) The Alzheimer β-amyloid protein precursor/protease nexin-II cleaved by secretase in a trans-Golgi secretory compartment in human neuroglioma cells. Biochem. J. 295, 367-378.
25. LaFerla F. M., Tinkle B. T., Bieberich C. J., Haudenschild C. C., and Jay G. (1995) The Alzheimer's Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Nature Genet. 9, 21-30.
26. Lane D. (1989) Immunoprecipitation, in Antibodies (Harlow L., ed), pp. 421-470. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York.
27. LeBlanc A.C. (1994) The role of β-amyloid peptide in Alzheimer's disease. Metab. Brain Dis. 9, 3-31.
28. LeBlanc A.C. (1995) Increased production of 4 kDa amyloid β peptide in serum deprived human primary neuron cultures: possible involvement of apoptosis. J. Neurosci. 15, 7837-7846.
29. LeBlanc A. and Gambetti P. (1994) Production of Alzheimer 4kDa β-amyloid peptide requires the C-terminal cytosolic domain of the amyloid precursor protein. Biochem. Biophys. Res. Commun. 204, 1371-1380.
30. LeBlanc A., Foldvari M., Spencer D., Breckenridge W., Fenwick R., Williams D., and Mezei C. (1989) The apolipoprotein A-1 gene is actively expressed in the rapidly myelinating avian peripheral nerve. J. Cell Biol. 109, 1245-1256.
31. LeBlanc A., Chen H., Autilio-Gambetti L., and Gambetti P. (1991) Differential APP gene expression in neonatal rat cerebral cortex, meninges and primary astroglial, neuronal and microglial cells. FEBS Lett. 292, 171-178.
32. LeBlanc A. C., Xue R., and Gambetti P. (1996) Amyloid precursor protein metabolism in primary cell cultures of neurons, astrocytes, and microglia. J. Neurochem. 66, 2300-2310.
33. Malhotra S. K., Shnita T. K., and Elbrink J. (1990) Reactive astrocytes - a review. Cytobios 61, 133-160.
34. Martin B. L., Schrader-Fisher G., Busciglio J., Duke M., Paganetti P., and Yankner B. A. (1995) Intracellular accumulation of β-amyloid in cells expressing the Swedish mutant amyloid precursor protein. J. Biol. Chem. 270, 26727-26730.
35. Munsick R. A. (1984) Human foetal extremity lengths in the interval from 9 to 21 menstrual weeks of pregnancy. Am. J. Obstet. Gynecol. 149, 883-887.
36. Nakamura T., Shoji M., Harigaya Y., Watanabe M., Hosoda K., Cheung T., Shaffer L., Golde T., Younkin L., Younkin S., and Hirai S. (1994) Amyloid β protein levels in cerebrovascular fluid are elevated in early-onset Alzheimer's disease. Ann. Neurol. 36, 903-911.
37. Palmert M., Podlinsny M., Witker D., Oltersdorf T., Younkin L., Selkoe D., and Younkin S. (1989) The β-amyloid protein precursor of Alzheimer disease has soluble derivatives found in human brain and cerebrospinal fluid. Proc. Natl. Acad. Sci. USA 86, 6338-6342.
38. Quon D., Wang Y., Catalano R., Scardina J., Murakami K., and Cordell B. (1991) Formation of β-amyloid protein deposits in brains of transgenic mice. Nature 352, 239-241.
39. Sambamurti K., Shioi J., Anderson M. A., Pappolla M. A., and Robakis N. K. (1992) Evidence for intracellular cleavage of the Alzheimer's amyloid precursor in PC12 cells. J. Neurosci. Res. 33, 319-329.
40. Seubert P., Oltersdorf T., Lee M., Barbour R., Blomquist C., Davis D., Bryant K., Fritz L. C., Galasko D., Thal L. J., Lieberburg I., and Schenk D. (1993) Secretion of β-amyloid precursor protein cleaved at the amino terminus of the β-amyloid peptide. Nature 361, 260-263.
41. Sheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N., Bird T., Hardy J., Hutton M., Kukull W., Larson E., Levy-Lahad E., Viitanen M., Peskind E., Poorkaj P., Schellenberg G., Tanzi R., Wasco W., Lannfelt L., Selkoe D., and Younkin S. (1996) Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med. 2, 864-870.
42. Shoji M., Golde T., Ghiso J., Cheung T., Estus S., Shaffer L., Cai X., McKay D., Tintner R., Frangione B., and Younkin S. (1992) Production of the Alzheimer amyloid β protein by normal proteolytic processing. Science 258, 126-129.
43. Siman R., Card P., Nelson R., and Davis L. (1989) Expression of β-amyloid precursor protein in reactive astrocytes following neuronal damage. Neuron 3, 275-285.
44. Simons M., DeStrooper B., Multhaup G., Tienari P. J., Dotti C. G., and Beyreuther K. (1996) Amyloidogenic processing of the human amyloid precursor protein in primary cultures of rat hippocampal neurons. J. Neurosci. 16, 899-908.
45. Suzuki N., Cheung T., Cai D., Odaka A., Laslo O., Eckman C., Golde T., and Younkin S. (1994) An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (βAPP117) mutants. Science 264, 1336-1340.
46. Tamaoka A., Okada A., Ishibashi Y., Usami M., Sahara N., Suzuki N., Nukina N., Mizusawa H., Shoji S., Kanazawa I., and Mori H. (1994) APP717 missense mutation affects the ratio of amyloid β protein species (1-42/43 and 1-40) in familial Alzheimer's disease brain. J. Biol. Chem. 269, 32721-32724.
47. Tanzi R., Gusella J., Watkins P., Bruns G., St. George-Hyslop P., Van Keuren M., Patterson D., Pagan S., Kurnit D., and Neve R. (1987) Amyloid β protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science 235, 880-884.
48. Teller J. K., Russo C., DeBusk L. M., Angelini G., Zaccheo D., Dagna-Bricarelli F., Scartezinni P., Bertolini S., Mann D. M. A., Tabaton M., and Gambetti P. (1996) Presence of soluble β-amyloid peptide precedes amyloid plaque formation in Down's syndrome. Nature Med. 2, 93-95.
49. Thinakaran G., Teplow D., Siman R., Greenberg B., and Sisodia S. (1996) Metabolism of the "Swedish" amyloid precursor protein variant in Neuro2A (N2a) cells. J. Biol. Chem. 271, 9390-9397.
50. Wasco W., Gurubhagavatula S., Paradis M., Romano D., Sisodia S., Hyman B., Neve R., and Tanzi R. (1993) Isolation and characterization of the human APL2 gene encoding a homologue of the Alzheimer's associated amyloid β protein precursor. Nature Genet. 5, 95-100.
51. Wertkin A. M., Turner R. S., Pleasure S. J., Golde T. E., Younkin S. G., Trojanowski J. Q., and Lee V. (1993) Human neurons derived from a teratocarcinoma cell line express solely the 695-amino acid amyloid precursor protein and produce intracellular β-amyloid or A4 peptides. Proc. Natl. Acad. Sci. USA 90, 9513-9517.
52. Wisniewski K., Wisniewski H., and Wen G. (1985) Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann. Neurol. 17, 278.
53. Yamazaki T., Selkoe D. J., and Koo E. H. (1995) Trafficking of cell surface β-amyloid precursor protein: retrograde and transcytotic transport in cultured neurons. J. Cell Biol. 129, 431-442.